Skip to main content

Published locations for Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapies

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ramucirumab effective in patients with advanced HCC and AFP ≥400 ng/mL after non-sorafenib therapies

User login

  • Reset your password
  • /content/ramucirumab-effective-patients-advanced-hcc-and-afp-400-ng/ml-after-non-sorafenib-therapies
  • /fedprac/article/258871/hepatocellular-carcinoma/ramucirumab-effective-patients-advanced-hcc-and-afp